ivi glutathione injection Injections, 200mg/mL Services

GHK was administered intraperitoneally at doses of 2.6, 26, and 260 g/ml/day every other day from the 4th to the 21st day after BLM instillation

Observed molecular and cellular responses are highly dependent on experimental conditions, concentration, exposure duration, and model system

Scale bar, 400 m

10.1007/s11481-019-09833-6 J

About Biogen Founded in 1978, Biogen is a leading global biotechnology company that has pioneered multiple breakthrough innovations including a broad portfolio of medicines to treat multiple sclerosis, the first approved treatment for spinal muscular atrophy, two co-developed treatments to address a defining pathology of Alzheimers disease, the first treatment to target a genetic form of ALS, the first oral treatment approved for postpartum depression, and the first approved treatment for Friedreichs ataxia